Evidence map›Paper›PMID 27911376›Full record

ArticleJournal of visualized experiments : JoVE2016

Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus.

Laura Ordovás, Ruben Boon, Mariaelena Pistoni, Yemiao Chen, Rangarajan Sambathkumar, Nicky Helsen, Jolien Vanhove, Pieter Berckmans, Qing Cai, Kim Vanuytsel and 2 more

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Laura OrdovásStem Cell Institute, Katholieke Universiteit Leuven; lordovas@unizar.es.
Ruben BoonStem Cell Institute, Katholieke Universiteit Leuven.
Mariaelena PistoniStem Cell Institute, Katholieke Universiteit Leuven.
Yemiao ChenStem Cell Institute, Katholieke Universiteit Leuven.
Rangarajan SambathkumarStem Cell Institute, Katholieke Universiteit Leuven.
Nicky HelsenStem Cell Institute, Katholieke Universiteit Leuven.
Jolien VanhoveStem Cell Institute, Katholieke Universiteit Leuven.
Pieter BerckmansStem Cell Institute, Katholieke Universiteit Leuven.
Qing CaiStem Cell Institute, Katholieke Universiteit Leuven.
Kim VanuytselStem Cell Institute, Katholieke Universiteit Leuven.
Susanna RaitanoStem Cell Institute, Katholieke Universiteit Leuven.
Catherine M VerfaillieStem Cell Institute, Katholieke Universiteit Leuven; catherine.verfiallie@kuleuven.be.
KU Leuven · BEStem Cell Institute · PA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Even with the revolution of gene-targeting technologies led by CRISPR-Cas9, genetic modification of human pluripotent stem cells (hPSCs) is still time consuming. Comparative studies that use recombinant lines with transgenes integrated into safe harbor loci could benefit from approaches that use site-specific targeted recombinases, like Cre or FLPe, which are more rapid and less prone to off-target effects. Such methods have been described, although they do not significantly outperform gene targeting in most aspects. Using Zinc-finger nucleases, we previously created a master cell line in the AAVS1 locus of hPSCs that contains a GFP-Hygromycin-tk expressing cassette, flanked by heterotypic FRT sequences. Here, we describe the procedures to perform FLPe recombinase-mediated cassette exchange (RMCE) using this line. The master cell line is transfected with a RMCE donor vector, which contains a promoterless Puromycin resistance, and with FLPe recombinase. Application of both a positive (Puromycin) and negative (FIAU) selection program leads to the selection of RMCE without random integrations. RMCE generates fully characterized pluripotent polyclonal transgenic lines in 15 d with 100% efficiency. Despite the recently described limitations of the AAVS1 locus, the ease of the system paves the way for hPSC transgenesis in isogenic settings, is necessary for comparative studies, and enables semi-high-throughput genetic screens for gain/loss of function analysis that would otherwise be highly time consuming.

Indexed as

Pluripotent Stem CellsRecombination, GeneticCell LineGene TargetingHumansRecombinasesTransgenesRecombinases

Identifiers

PMID27911376
PMCPMC5226264
OpenAlexW2553289377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.